Inhibition of soluble guanylate cyclase activity by citrate.
Soluble guanylate cyclase activity from guinea pig heart is inhibited by increasing concentrations of sodium citrate. The Ki value was found to be 2.83 +/- 0.05 mM in the presence of 3 mM Mn2+ and 0.6 mM GTP. Citrate acts by lowering Vmax and increasing the apparent values of Km for GTP and K0.5 for Mn2+ and Mg2+. The soluble guanylate cyclase, activated by sodium nitroprusside, was also inhibited by citrate. This inhibitory action of citrate was not restricted to soluble guanylate cyclase activity of the heart and has been demonstrated also in the supernatant of lung, liver, diencephalon and in the homogenate of blood platelets. Since citrate is known to be an important intermediate of metabolism, its intracellular concentration may be also of relevance for guanylate cyclase activity.
D000818:Animals; D001792:Blood Platelets / Q000187:drug effects; D002951:Citrates / Q000494:pharmacology*; D004027:Diencephalon / Q000187:drug effects; D006162:Guanylate Cyclase / Q000037:antagonists & inhibitors*; D006168:Guinea Pigs; D006321:Heart / Q000187:drug effects*; D008099:Liver / Q000187:drug effects; D008297:Male; D009206:Myocardium / Q000201:enzymology*; D051381:Rats
D002951:Citrates; D006162:Guanylate Cyclase